Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,050 | 361 | 66.6% |
| Consulting Fee | $2,475 | 1 | 20.5% |
| Travel and Lodging | $1,567 | 5 | 13.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ARGENX US, INC. | $4,695 | 22 | $0 (2024) |
| ABBVIE INC. | $676.78 | 61 | $0 (2024) |
| Lilly USA, LLC | $634.00 | 19 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $423.30 | 14 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $417.97 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $407.94 | 23 | $0 (2024) |
| CSL Behring | $337.37 | 16 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $332.58 | 12 | $0 (2024) |
| PFIZER INC. | $323.54 | 28 | $0 (2024) |
| SK Life Science, Inc. | $310.27 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,528 | 210 | ARGENX US, INC. ($4,478) |
| 2023 | $3,317 | 144 | ABBVIE INC. ($253.26) |
| 2022 | $247.35 | 13 | Lilly USA, LLC ($50.64) |
All Payment Transactions
367 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.65 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| Category: Neurology | ||||||
| 12/06/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Neurology | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $37.47 | General |
| Category: NEUROLOGY | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.82 | General |
| Category: Narcoplepsy | ||||||
| 11/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $30.93 | General |
| 11/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $208.33 | General |
| Category: Neurology | ||||||
| 11/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Neurology | ||||||
| 11/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Neurology | ||||||
| 11/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $46.14 | General |
| Category: Neurology | ||||||
| 11/14/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $702.82 | General |
| Category: Neurology | ||||||
| 11/14/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $303.03 | General |
| Category: Neurology | ||||||
| 11/14/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $183.33 | General |
| Category: Neurology | ||||||
| 11/14/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $106.08 | General |
| Category: Neurology | ||||||
| 11/14/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $34.81 | General |
| Category: Neurology | ||||||
| 11/12/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 913 | 2,316 | $399,340 | $116,744 |
| 2022 | 3 | 104 | 110 | $21,655 | $7,026 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 493 | 1,183 | $307,580 | $93,399 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 223 | 316 | $58,460 | $17,024 | 29.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 33 | 94 | $11,280 | $3,610 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 20 | $7,280 | $2,258 | 31.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 27 | 27 | $1,080 | $333.45 | 30.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 58 | 176 | $6,160 | $74.73 | 1.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 66 | 500 | $7,500 | $46.05 | 0.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 58 | $15,080 | $4,920 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 31 | $5,735 | $1,847 | 32.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 19 | 21 | $840.00 | $259.35 | 30.9% |
About Jennifer Reeves, APRN
Jennifer Reeves, APRN is a Family healthcare provider based in Panama City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2022. The National Provider Identifier (NPI) number assigned to this provider is 1720700529.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Reeves, APRN has received a total of $12,092 in payments from pharmaceutical and medical device companies, with $8,528 received in 2024. These payments were reported across 367 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($8,050).
As a Medicare-enrolled provider, Reeves has provided services to 1,017 Medicare beneficiaries, totaling 2,426 services with total Medicare billing of $123,771. Data is available for 2 years (2022–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Acute Care
- Location Panama City, FL
- Active Since 09/19/2022
- Last Updated 09/10/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1720700529
Products in Payments
- VYVGART HYTRULO (Drug) $4,478
- UBRELVY (Drug) $358.04
- Hizentra (Biological) $337.37
- ULTOMIRIS (Biological) $332.58
- KESIMPTA (Drug) $326.67
- QULIPTA (Drug) $318.74
- XYWAV (Drug) $276.74
- Gocovri (Drug) $263.77
- Ocrevus (Biological) $249.02
- REXULTI (Drug) $239.06
- NURTEC ODT (Drug) $236.97
- NUEDEXTA (Drug) $218.14
- VYVGART (Drug) $217.33
- VYEPTI (Biological) $215.63
- NUPLAZID (Drug) $205.63
- KISUNLA (Drug) $205.33
- Leqembi (Drug) $192.09
- Senza (Device) $189.38
- AMYVID (Drug) $182.92
- Vercise (Device) $169.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Panama City
Andrew Rising, Aprn, APRN
Family — Payments: $9,388
Mrs. Sarah Rowe, Msn, Fnp-Bc, Ocn, MSN, FNP-BC, OCN
Family — Payments: $8,513
Dr. Tracy Adams, Dnp, Arnp, Fnp-C, DNP, ARNP, FNP-C
Family — Payments: $6,642
Ashli Brooks, Fnp-Bc, FNP-BC
Family — Payments: $6,201
Dr. Sarah Stokes, Dnp, Arnp-Bc, DNP, ARNP-BC
Family — Payments: $5,024
Mary Carmon, Np, NP
Family — Payments: $4,682